Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial
Kenji Suzuki(Juntendo University), Hisao Asamura, Keiju Aokage(National Cancer Center Hospital East), Junki Mizusawa(Japan Clinical Cancer Research Organization), Masahiro Tsuboi(National Cancer Center Hospital East), Hisashi Saji(St. Marianna University School of Medicine), Shun‐ichi Watanabe(Tokyo National Hospital), Tetsuya Mitsudomi(Kindai University), Kenichi Nakamura(Japan Clinical Cancer Research Organization), Shinichiro Nakamura(Japan Clinical Cancer Research Organization), Morihito Okada(Hiroshima University), Ryu Nakajima(Osaka City General Hospital)
Cited by 496
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival
|Cancer Research|2004|2.4k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k